tiprankstipranks
Trending News
More News >
Wuxi Biologics (Cayman) Inc. (HK:2269)
:2269
Hong Kong Market

Wuxi Biologics (Cayman) (2269) Cash flow

Compare
42 Followers

Wuxi Biologics (Cayman) Cash Flow

HK:2269's free cash flow for Q4 2024 was ¥1.85B. For the 2024 fiscal year, HK:2269's free cash flow was decreased by ¥850.44M and operating cash flow was ¥3.92B. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
¥ 5.22B¥ 4.67B¥ 5.54B¥ 3.43B¥ 1.88B
Investing Cash Flow
¥ -3.94B¥ -3.23B¥ -5.91B¥ -9.60B¥ -7.22B
Financing Cash Flow
¥ -2.75B¥ 1.96B¥ -2.59B¥ 8.21B¥ 6.57B
End Cash Position
¥ 8.28B¥ 9.67B¥ 6.40B¥ 9.00B¥ 7.10B
Free Cash Flow
¥ 1.29B¥ 437.20M¥ -326.72M¥ -3.09B¥ -4.14B
Currency in CNY

Wuxi Biologics (Cayman) Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis